MedTrace Logo

Microbiome Sampling in GI Disease With a Focus on Small Intestinal Microbial Assessment

NCT06066866 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-10-06

No results posted yet for this study

Summary

GI disorders are influenced by the gut microbiome. To date, sampling of the small intestine in GI disorders has been limited. The investigators plan to sample the small intestinal contents during endoscopy for research purposes.

Conditions

  • Healthy
  • IBS - Irritable Bowel Syndrome
  • Inflammatory Bowel Diseases

Interventions

OTHER

endoscopic sampling of luminal fluid

We will collect luminal fluid via endoscopic sampling

Sponsors & Collaborators

Principal Investigators

  • Sean P Spencer, MD,PhD · Stanford University

  • Linda A Nguyen, MD · Stanford University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-01-01
Completion
2028-01-01

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06066866 on ClinicalTrials.gov